While the expression of CD123 and CLEC12A showed correlation with AML with FLT3 mutations with or without NPM1 mutations, the low AUC indicated the limited utility of these markers in predicting the mutational status of FLT3. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.